Drug Shortage Report for MYLAN-NIFEDIPINE EXTENDED RELEASE
| Report ID | 104685 |
| Drug Identification Number | 02321149 |
| Brand name | MYLAN-NIFEDIPINE EXTENDED RELEASE |
| Common or Proper name | NIFEDIPINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | NIFEDIPINE |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-20 |
| Estimated end date | 2020-07-07 |
| Actual end date | 2020-06-09 |
| Shortage status | Resolved |
| Updated date | 2020-06-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-01-29 | French | Compare |
| v1 | 2020-01-29 | English | Compare |